PTHS vs RPID
Comparison between Channel Therapeutics Corporation (PTHS, Company) and Rapid Micro Biosystems Inc - Class A (RPID, Company).
Both PTHS and RPID are from the Healthcare sector.
PTHS vs RPID - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
PTHS
$96M
RPID
$96M
Max Drawdown
Winner
PTHS
88.73%
RPID
97.57%
Sharpe Ratio
Winner
PTHS
0.81
RPID
-0.39
5Y Beta
Winner
PTHS
1.08
RPID
1.52
Industry
PTHS
Biotechnology
RPID
Medical Devices
P/E Ratio
PTHS
-0.73
Winner
RPID
-1.93
PEG Ratio
Winner
PTHS
-0.00
RPID
0.00
Debt to Equity
Winner
PTHS
0.00%
RPID
93.41%
Free Cash Flow Yield
Winner
PTHS
-36.78%
RPID
-39.62%
P/S Ratio
PTHS
3.58
Winner
RPID
3.06
P/B Ratio
Winner
PTHS
2.84
RPID
5.15
PTHS vs RPID - Historical Returns
Returns include dividend reinvestment.
1M
Winner
PTHS
+9.23%
RPID
-16.59%
3M
Winner
PTHS
+8.01%
RPID
-33.72%
6M
Winner
PTHS
+28.86%
RPID
-58.09%
1Y
Winner
PTHS
+52.63%
RPID
-47.55%
5Y(CAGR)
PTHS
N/A
RPID
-39.79%
Max(CAGR)
Winner
PTHS
-18.38%
RPID
-39.25%
PTHS vs RPID - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | PTHS | RPID |
|---|---|---|
| 2026 | -1.53% | -45.54% |
| 2025 | +328.54% | +194.99% |
| 2024 | -86.65% | -0.78% |
| 2023 | N/A | -39.34% |
| 2022 | N/A | -89.57% |
| 2021 | N/A | -50.28% |
PTHS vs RPID Drawdown Comparison
The maximum drawdown for PTHS was -88.73%, occurring on Nov 19, 2024. This drawdown has not yet recovered.
The maximum drawdown for RPID was -97.57%, occurring on Jul 3, 2024. This drawdown has not yet recovered.
The current PTHS drawdown is -39.58%. The current RPID drawdown is -93.10%.
| Rank | PTHS | RPID |
|---|---|---|
| #1 | -88.73% Feb 16, 2024 - Nov 19, 2024 | -97.57% Aug 5, 2021 - Jul 3, 2024 |
| #2 | N/A | -17.01% Jul 16, 2021 - Aug 3, 2021 |
Correlation
Correlation between PTHS and RPID is 0.39 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.39
-101
Select Stocks to Compare
Popular: PTHS vs SPYRPID vs SPY
More Comparisons
Compare with similar stocks